Gene Discovery May Unlock Key to Obesity Syndrome

OCTOBER 01, 2004
Susan Farley

Scientists in the United States, Great Britain, and Canada were able to identify the last of 8 genes known to contribute to Bardet-Biedl syndrome (BBS), a rare disorder that combines the common problems of obesity, learning difficulties, diabetes, and asthma. The researchers think that the gene, known as BBS3/ARL6, can be used to understand the other BBS proteins and what causes BBS and, by extension, obesity and other BBS-related problems.



SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.